Osteoarthritis Trial, Recruiting NCT04049279 Sponsor: JointResearch Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT04049279
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled for a planned, first-time cemented total hip replacement surgery.
  • Men aged 70 or older, or women aged 65 or older.
  • People who are able and willing to follow study instructions and attend follow-up appointments.
  • People who understand what the study involves and are willing to sign a consent form agreeing to take part.
  • People who understand the Dutch language.

Who may not be able to join:

  • People with a Body Mass Index (BMI) of 40 or higher (classified as morbidly obese).
  • People who are expected to need a joint replacement in another leg joint within the next year.
  • People who have a whole-body or metabolism-related condition that causes ongoing bone loss.
  • People who have a deformity or disease in a joint other than the hip that requires surgery and affects their ability to walk.
  • People who have an active or suspected hidden infection in or around the hip joint.
  • People whose bone quality is too poor — due to disease or infection — to properly support or hold a hip implant in place.
  • People who are unwilling or unable to sign the study consent form.
  • People whom the trial investigator considers unsuitable for participation for any reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rudolf Poolman, MD, PhD, OLVG

Phone: +31(0)20-5993653

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
JointResearch
Registry
ClinicalTrials.gov
Start date
1 January 2019
Est. completion
1 May 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Migration of the acetabular cup

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov